KathrynWagnerMD

Neurology • Baltimore, MD

Neurophysiology

Professor, Neurology, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Wagner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wagner's full profile

Already have an account?

Office
1800 Orleans St.,Sheikh Zayed Tower
Baltimore, MD 21287
Phone+1 443-923-9525

Fax+1 443-923-9405

Education & Training

Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 1998 - 1999
Johns Hopkins UniversityResidency, Neurology, 1995 - 1998
Johns Hopkins UniversityResidency, Internal Medicine, 1994 - 1995
Johns Hopkins University School of MedicineClass of 1994

Certifications & Licensure

MD State Medical License 1998 - 2025
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Start of enrollment: 2010 Sep 01
Terminated
Phase 2
Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
Completed
Phase 3
Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy Start of enrollment: 2012 Mar 01
Active, not recruiting
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping Start of enrollment: 2012 Sep 01
Unknown status
A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects Start of enrollment: 2013 May 01
Terminated
Phase 3
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy
Approved for marketing
A Trial of PF-06252616 in Ambulatory Participants With LGMD2I Start of enrollment: 2016 Jul 01
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

3 citations
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial.
Rabi Tawil, Kathryn R Wagner, Johanna I Hamel, Doris G Leung, Jeffrey M Statland
The Lancet. Neurology. 2024-05-01
1 citations
Lean tissue mass measurements by dual-energy X-ray absorptiometry and associations with strength and functional outcome measures in facioscapulohumeral muscular dystro...
Leo H Wang, Doris G Leung, Kathryn R Wagner, Sarah J Lowry, Michael P McDermott
Neuromuscular Disorders. 2023-09-01
5 citations
Engineering Skeletal Muscle Grafts with PAX7::GFP-Sorted Human Pluripotent Stem Cell-Derived Myogenic Progenitors on Fibrin Microfiber Bundles for Tissue Regeneration.
Sarah M Somers, Jordana Gilbert-Honick, In Young Choi, Emily K W Lo, HoTae Lim
Bioengineering. 2022-11-15

Press Mentions

Longitudinal Functional and Imaging Outcome Measures in FKRP Limb-Girdle Muscular DystrophyMay 19th, 2020
Catabasis Pharmaceuticals Provides Update on Global Phase 3 PolarisDMD Trial for Edasalonexent at Parent Project Muscular Dystrophy 25th Annual ConferenceJune 27th, 2019

Professional Memberships

American Academy of Neurology - AAN
Member

External Links

Wagner labhttps://www.thewagnerlab.org/